Ceftazidime-Avibactam as Osteomyelitis Therapy: A Miniseries and Review of the Literature
Bone and joint infections (BJIs) caused by multidrug-resistant gram-negative bacteria are becoming a concern due to limited therapeutic options. Although not approved for these indications, an ever-growing amount of evidence supports the efficacy and safety of ceftazidime–avibactam as a therapy for...
Bewaard in:
| Hoofdauteurs: | , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
MDPI AG
2023-08-01
|
| Reeks: | Antibiotics |
| Onderwerpen: | |
| Online toegang: | https://www.mdpi.com/2079-6382/12/8/1328 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|